Jamie L. Lesnock

Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 13, 2026

ASCO neoadjuvant chemotherapy in ovarian cancer guideline: A SGO endorsement.

Journal: Gynecologic oncology

Published: October 14, 2025

Ovary Sparing Intensity Modulated Radiotherapy Following Ovarian Transposition: A Single Institution Retrospective Dosimetric Analysis of Patients with Cervical Cancer Treated with External Beam Radiation Therapy After Oophoropexy.

Journal: Practical radiation oncology

Published: October 10, 2025

What is the optimal fractionation for image-based high-dose-rate brachytherapy boost in medically inoperable endometrial cancer: 4 versus 5 fractions?

Journal: Brachytherapy

Published: October 08, 2025

Cytologic Detection of Metastatic Immature Teratomas in Two Young Patients With Unique Presentations.

Journal: Diagnostic cytopathology

Published: April 28, 2025

The Role of Adjuvant Chemotherapy in Endometrial Cancer Following Preoperative Neoadjuvant Chemoradiation Therapy.

Journal: American journal of clinical oncology

Published: April 23, 2025

Beyond GOG258 and PORTEC3: A National Cancer Database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer.

Journal: Gynecologic oncology reports

Published: March 19, 2025

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 22, 2025

All-cause mortality and neighborhood social vulnerability among women with ovarian cancer.

Journal: Gynecologic oncology

Published: January 21, 2025

Hysterectomy with sentinel lymph node dissection in the setting of preoperative endometrial intraepithelial neoplasia and an endometrial stripe ≥20 mm: a cost-effectiveness analysis .

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 06, 2024

Association of neighborhood social vulnerability with ovarian cancer survival.

Journal: Gynecologic oncology

Published: June 27, 2024

Use of indocyanine green dye for sentinel lymph node mapping in patients with endometrial cancer and a history of iodinated contrast allergy.

Journal: Gynecologic oncology reports

Published: June 05, 2024

Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0.

Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0.

ASCO neoadjuvant chemotherapy in ovarian cancer guideline: A SGO endorsement.

ASCO neoadjuvant chemotherapy in ovarian cancer guideline: A SGO endorsement.

Ovary Sparing Intensity Modulated Radiotherapy Following Ovarian Transposition: A Single Institution Retrospective Dosimetric Analysis of Patients with Cervical Cancer Treated with External Beam Radiation Therapy After Oophoropexy.

Ovary Sparing Intensity Modulated Radiotherapy Following Ovarian Transposition: A Single Institution Retrospective Dosimetric Analysis of Patients with Cervical Cancer Treated with External Beam Radiation Therapy After Oophoropexy.

What is the optimal fractionation for image-based high-dose-rate brachytherapy boost in medically inoperable endometrial cancer: 4 versus 5 fractions?

What is the optimal fractionation for image-based high-dose-rate brachytherapy boost in medically inoperable endometrial cancer: 4 versus 5 fractions?

Cytologic Detection of Metastatic Immature Teratomas in Two Young Patients With Unique Presentations.

Cytologic Detection of Metastatic Immature Teratomas in Two Young Patients With Unique Presentations.

The Role of Adjuvant Chemotherapy in Endometrial Cancer Following Preoperative Neoadjuvant Chemoradiation Therapy.

The Role of Adjuvant Chemotherapy in Endometrial Cancer Following Preoperative Neoadjuvant Chemoradiation Therapy.

Beyond GOG258 and PORTEC3: A National Cancer Database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer.

Beyond GOG258 and PORTEC3: A National Cancer Database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer.

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.

All-cause mortality and neighborhood social vulnerability among women with ovarian cancer.

All-cause mortality and neighborhood social vulnerability among women with ovarian cancer.

Hysterectomy with sentinel lymph node dissection in the setting of preoperative endometrial intraepithelial neoplasia and an endometrial stripe ≥20 mm: a cost-effectiveness analysis .

Hysterectomy with sentinel lymph node dissection in the setting of preoperative endometrial intraepithelial neoplasia and an endometrial stripe ≥20 mm: a cost-effectiveness analysis .

Association of neighborhood social vulnerability with ovarian cancer survival.

Association of neighborhood social vulnerability with ovarian cancer survival.

Use of indocyanine green dye for sentinel lymph node mapping in patients with endometrial cancer and a history of iodinated contrast allergy.

Use of indocyanine green dye for sentinel lymph node mapping in patients with endometrial cancer and a history of iodinated contrast allergy.

Hysterectomy with sentinel lymph node dissection in the setting of preoperative endometrial intraepithelial neoplasia and an endometrial stripe ≥20 mm: a cost-effectiveness analysis .

Hysterectomy with sentinel lymph node dissection in the setting of preoperative endometrial intraepithelial neoplasia and an endometrial stripe ≥20 mm: a cost-effectiveness analysis .